From: Type of arteriovenous vascular access and association with patency and mortality
Fistula | Graft | |||
---|---|---|---|---|
N=727 | N=146 | |||
Age (years) (IQR) | 65.8 | (54.5-73.7) | 68.5 | (59.4-74.3) |
Sex, female (%) | 37.4 | 59.6 | ||
BMI (kg/m2) (IQR) | 24.0 | (22.0-26.7) | 24.8 | (21.5-27.8) |
Primary kidney disease (%) | ||||
Diabetes mellitus | 14.7 | 17.8 | ||
Glomerulonephritis | 12.0 | 5.5 | ||
Renal vascular disease | 19.1 | 28.1 | ||
Others | 54.2 | 48.6 | ||
Cardiovascular disease (%) | 40.0 | 42.5 | ||
Prior catheter use (%) | 26.8 | 32.2 | ||
Systolic blood pressure, mmHg | 148 | (135–162) | 144 | (133–158) |
GFR (ml/min/1.73 m2) (IQR) | 3.2 | (1.7-5.0) | 2.4 | (1.1-4.4) |
Calcium (mmol/L) (IQR) | 2.4 | (2.2-2.5) | 2.4 | (2.2-2.6) |
Phosphorus (mmol/L) (IQR) | 1.8 | (1.5-2.2) | 1.8 | (1.5-2.2) |
Serum cholesterol (mmol/L) (IQR) | 4.6 | (3.9-5.4) | 4.9 | (4.1-6.0) |
Serum albumin (g/L) (IQR) | 37 | (34–40) | 36 | (32–40) |
hsCRP* (mg/L) (IQR) | 5.3 | (2.0-13.8) | 6.5 | (2.5-16.7) |
Fetuin-A* (g/L) (IQR) | 0.6 | (0.5-0.7) | 0.6 | (0.5-0.8) |